Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07318077 · ClinicalTrials.gov registry record · NA

Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes

A NA study of GI Health and Belly Pain, sponsored by Radicle Science.

Recruiting
Registry status
NA
Development phase
825
Enrollment target
1
Study location

NCT07318077 is a NA study of GI Health and Belly Pain that is actively recruiting participants, run by Radicle Science. The registered enrollment target is 825 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07318077, a NA study of GI Health and Belly Pain, is actively recruiting participants, sponsored by Radicle Science.

RECRUITING
Registry status
NA
Development phase
825 participants
Enrollment target
1
Study location

Study Summary

Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT GI Health Product Placebo Control
  • DIETARY_SUPPLEMENT GI Health Active Product 1
  • DIETARY_SUPPLEMENT GI Health Active Product 2

Study Locations (1)

California

  • Radicle Science Inc. - Del Mar

Trial Details

FieldValue
Enrollment Target 825 participants
Start Date 2026-01-06
Est. Completion 2027-01-13
Phase NA

Sponsor

Radicle Science

55 total trials

What the Registry Record Tells You About NCT07318077

The ClinicalTrials.gov registry entry for NCT07318077 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with GI Health appearing as the primary indexed condition, and to 3 interventions - of which GI Health Product Placebo Control is the first listed.

NCT07318077 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07318077 about?

NCT07318077 is a clinical study titled "Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes". Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.

What is the current status of trial NCT07318077?

This trial is currently recruiting. It is a NA study. The enrollment target is 825 participants. The study started on 2026-01-06. Estimated completion is 2027-01-13.

What conditions does trial NCT07318077 study?

This clinical trial studies the following conditions: GI Health, Belly Pain.

What interventions are being tested in trial NCT07318077?

The interventions under investigation include: GI Health Product Placebo Control (DIETARY_SUPPLEMENT), GI Health Active Product 1 (DIETARY_SUPPLEMENT), GI Health Active Product 2 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07318077?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07318077 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for GI Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.